Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Mol Genet Metab. 2008 Aug 3;95(1-2):31–38. doi: 10.1016/j.ymgme.2008.06.006

Table 2.

Novel sequence variants identified in PC gene and relative PC protein ratio

ID Type DNA1 Protein2 Protein amount3 PC Activity4
1 C c. [796T>G; =] + [=; 2114C>A, =] * p. [S266A; =] + [=; S705X, =] 86 ± 5.8% 1.9%
2 B c. [1892G>A, =; =] + [=; 2493_2494delGT, =] p. [R631Q, =; =] + [=; V831VfsX832,=] 8 ± 0.2% 0
3 B c. [321+1G>T] + [321+1G>T] p. [V105_K107del] + [V105_K107del] 3 ± 1.4% 0
4 B c.[806G>A] + [806G>A] p. [R269Q] + [R269Q] 2 ± 0.1% 5%
5 B c. [467G>A; 496G>A; 1892G>A, =; 2540C>T, =] + [467G>A; 496G>A; =; =] p. [R156Q; V166I; R631Q, =; A847V, =] + [R156Q; V166I; =; =] 44 ± 2.8% 1.9%
6 A c. [184C>T; 1892G>A ; 2540C>T] + [=; 1892G> A, =; 2540C> T, =] p. [R62C; R631Q; 847V] + [=; R631Q, =; A847V, =] 49 ± 17.6% 6%
7 B c. [1892G>A; 2540C> T]+
[1892G>A, =; 2540C> T, = ]
p. [R631Q; A847V] + [R631Q, =; A847V, =] 17 ± 8.2% 17%
8 C c. [1705A>G; =] + [=; 3499–3500delCT] p.[T569A; =] + [=; L1137VfsX1170] N/A 1%
P1 A c. [434T>C] + [434T>C] p. [V145A] + [V145A] Barely detectable 7–25%
P2 A c. [1351C>T] + [1351C>T] p. [R451C] + [R451C] ~100% 7%
P3 A c. [1828G>A] + [1828G>A] p. [A610>T] + [A610T] ~100% 1–4%
P4 A c. [2229G>T] + [2229G>T] p. [M743I] + [M743I] ~100% 1–4%
P5 B c. [2493_2494delGT] + [2473+2-2473+5delTGCA] p. [V831VfsX832] + [E825GfsX846] ~0 1–4%
1

The nomenclature follows the recommendations for the description of sequence variants (www.hgvs.org/mutnomen/recs.html;http://www.hgvs.org/mutnomen/; http://www.hgvs.org/mutnomen/checklist.html; Hum Mutat 22:181–182, 2003; http://dx.doi.org/10.1002/humu.10262; Hum Mut 15: 7–12, 2000). The coding sequence is NM_000920. 3. Nucleotide +1 is the A of the ATG translation initiation codon. c. [2114C>A, =]

*

indicates the mosaic state of this allele, more ‘2114C>A’ than ‘=’ (wild-type) in the total DNA level. c. [1892G>A, =; 2540C> T, =]

indicates the mosaic state of the two substitutions 1892G>A and 2549C>T in this allele, which are more abundant than the ‘=’ (wild-type).

2

Note, changes are deduced based on the findings in DNA level. “0”, indicates no protein; “=”, indicates WT protein synthesized.

3

The PC /MCC +PCC ratios in PC patients are normalized to the ratio in normal control (Mean ± SD) (Fig. 4).

4

the PC activity is expressed as the ratio of patient/ control.

P1-2 and P5 were reported by Carbone et al. (3, 24). P3-4 were reported by Wexler et al.,(33).